« Biogen Idec, Elan to submit MS drug for European approval | Main | Wild Dog Urine May Be Used as "Fences" in Africa »

IVAX, Serono say oral cladribine trials for MS positive

The Swiss pharmaceuticals group Serono and its US partner IVAX Corp. posted positive results from two clinical trials with an oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).

"This is a major step in the development of the first oral disease modifying treatment for multiple sclerosis."

That would be nice.

Swallow here.

March 23, 2004 in follow the money..., research, worth following... | Permalink

Comments